Botulinum toxin for treatment of craniofacial hyperhidrosis.
A Böger, H Herath, R Rompel...
https://pubmed.ncbi.nlm.nih.gov/11151418/Actively Recruiting
Led by Tishreen University · Updated on 2026-05-01
30
Participants Needed
1
Research Sites
16 weeks
Total Duration
Primary frontal hyperhidrosis is a chronic condition characterized by excessive sweating in the forehead area, which can greatly affect a persons quality of life due to its visibility and impact on daily activities. This research aims to assess the safety and effectiveness of intradermal injections of Botulinum Toxin Type A for treating this condition. Clinical outcomes will be evaluated using the Hyperhidrosis Disease Severity Scale HDSS, Minors iodine-starch test, and patient satisfaction scores, with follow-up one month after treatment to monitor results and side effects. Participants will receive injections of Botulinum Toxin Type A directly into the affected frontal area. The treatment area is identified using Minors iodine-starch test and divided into a grid for precise injection placement. Each injection delivers 2 units of the toxin, with a total dose ranging from 40 to 80 units depending on the size of the affected region. The injections are given using a fine needle, and the treatment is performed during a single visit. During the study, participants will undergo baseline assessments including the HDSS score and Minors test to map sweating areas. One month after treatment, these assessments will be repeated to measure changes in sweating severity and area. Patient satisfaction will also be recorded using a questionnaire. Safety monitoring will include tracking any adverse effects experienced during the follow-up period. The study is conducted on adults aged 18 to 40 years and aims to provide detailed data on treatment effects and safety over this four-week period.
CONDITIONS
Botulinum Toxin Type A for Frontal Hyperhidrosis
Z
Zeinab Y Mohammad, MD
M
Mohamad A Ismaiel, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tishreen University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment visit
Participants receive intradermal injections of botulinum toxin type A in the affected frontal area. Injection sites are identified using Minor's iodine-starch test, followed by standardized grid-based mapping to ensure precise localization and uniform distribution of the toxin.
1 visit (in-person)
Duration - 4 weeks after treatment
Participants return for evaluation one month after treatment to assess changes in sweating area, severity of hyperhidrosis, patient satisfaction, and any adverse effects.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
A Böger, H Herath, R Rompel...
https://pubmed.ncbi.nlm.nih.gov/11151418/Tishreen University
Lead Sponsor